Transcatheter Embolization and Occlusion Devices Market Research Report by Product (Coiled Devices and Non-Coiled Devices), Indication (Peripheral Vascular Disease, Oncology, Neurology and Urology), End User (Hospitals, Clinics and Ambulatory Surgery Centers) and Region - Forecast till 2032

Table of Contents

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Transcatheter Embolization and Occlusion Devices Market, by Product

6.1 Introduction

6.2 Coiled Devices

6.2.1 Pushable Coils

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.2.2 Detachable Coils

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3 Non-Coiled Devices

6.3.1 Flow-Diverting Devices

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.2 Embolization Particles

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.3 Liquid Embolic

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.4 Other Embolization and Occlusion Devices

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3.5 Accessories

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 7 Global Transcatheter Embolization and Occlusion Devices Market, by Indication

7.1 Introduction

7.2 Peripheral Vascular Disease

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3 Oncology

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4 Neurology

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.5 Urology

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.6 Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 8 Global Transcatheter Embolization and Occlusion Devices Market, by End User

8.1 Introduction

8.2 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.3 Ambulatory Surgery Centers (ASCs)

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.4 Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

Chapter 9 Global Transcatheter Embolization and Occlusion Devices Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Developments & Strategies

Chapter 11 Company Profiles

11.1 Medtronic plc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.1.6 Key Strategies

11.2 Stryker Corporation

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Boston Scientific Corporation

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Terumo Corporation

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.6 Key Strategies

11.5 Pfizer Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 DePuy Synthes

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategies

11.7 Cardinal Health

11.7.1 Company Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Abbott Laboratories

11.8.1 Company Overview

11.8.2 Product Overview

11.8.3 Financial Overview

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

11.9 Cook Medical

11.9.1 Company Overview

11.9.2 Product Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategies

11.10 Sirtex Medical Limited

11.10.1 Company Overview

11.10.2 Product Overview

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

11.11 Merit Medical Systems

11.11.1 Company Overview

11.11.2 Product Overview

11.11.3 Financial Overview

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategies

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Transcatheter Embolization and Occlusion Devices Industry

Chapter 13 Appendix

List of Tables

Table 1 Global Transcatheter Embolization and Occlusion Devices Market Synopsis, 2022-2030

Table 2 Global Transcatheter Embolization and Occlusion Devices Market Estimates and Forecast, 2022-2030 (USD Million)

Table 3 Global Transcatheter Embolization and Occlusion Devices Market, by Region, 2022-2030 (USD Million)

Table 4 Global Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 5 Global Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 6 Global Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 7 North America: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 8 North America: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 9 North America: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 10 US: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 11 US: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 12 US: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 13 Canada: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 14 Canada: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 15 Canada: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 16 Latin America: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 17 Latin America: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 18 Latin America: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 19 Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 20 Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 21 Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 22 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 23 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 24 Western Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 25 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 26 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 27 Eastern Europe: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 28 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 29 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 30 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

Table 31 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by Product, 2022-2030 (USD Million)

Table 32 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by Indication, 2022-2030 (USD Million)

Table 33 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market, by End User, 2022-2030 (USD Million)

List of Figures

Figure 1 Research Process

Figure 2 Segmentation for Global Transcatheter Embolization and Occlusion Devices Market

Figure 3 Segmentation Market Dynamics for Global Transcatheter Embolization and Occlusion Devices Market

Figure 4 Global Transcatheter Embolization and Occlusion Devices Market Share, by Product, 2022

Figure 5 Global Transcatheter Embolization and Occlusion Devices Market Share, by Indication, 2022

Figure 6 Global Transcatheter Embolization and Occlusion Devices Market Share, by End User, 2022

Figure 7 Global Transcatheter Embolization and Occlusion Devices Market Share, by Region, 2022

Figure 8 North America: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2022

Figure 9 Europe: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2022

Figure 10 Asia-Pacific: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2022

Figure 11 Middle East & Africa: Transcatheter Embolization and Occlusion Devices Market Share, by Country, 2022

Figure 12 Global Transcatheter Embolization and Occlusion Devices Market: Company Share Analysis, 2022 (%)

Figure 13 Medtronic plc: Key Financials

Figure 14 Medtronic plc: Segmental Revenue

Figure 15 Medtronic plc: Geographical Revenue

Figure 16 Stryker Corporation: Key Financials

Figure 17 Stryker Corporation: Segmental Revenue

Figure 18 Stryker Corporation: Geographical Revenue

Figure 19 Boston Scientific Corporation: Key Financials

Figure 20 Boston Scientific Corporation: Segmental Revenue

Figure 21 Boston Scientific Corporation: Geographical Revenue

Figure 22 Terumo Corporation: Key Financials

Figure 23 Terumo Corporation: Segmental Revenue

Figure 24 Terumo Corporation: Geographical Revenue

Figure 25 Pfizer Inc.: Key Financials

Figure 26 Pfizer Inc.: Segmental Revenue

Figure 27 Pfizer Inc.: Geographical Revenue

Figure 28 DePuy Synthes: Key Financials

Figure 29 DePuy Synthes: Segmental Revenue

Figure 30 DePuy Synthes: Geographical Revenue

Figure 31 Cardinal Health: Key Financials

Figure 32 Cardinal Health: Segmental Revenue

Figure 33 Cardinal Health: Geographical Revenue

Figure 34 Abbott Laboratories: Key Financials

Figure 35 Abbott Laboratories: Segmental Revenue

Figure 36 Abbott Laboratories: Geographical Revenue

Figure 37 Cook Medical: Key Financials

Figure 38 Cook Medical: Segmental Revenue

Figure 39 Cook Medical: Geographical Revenue

Figure 40 Sirtex Medical Limited: Key Financials

Figure 41 Sirtex Medical Limited: Segmental Revenue

Figure 42 Sirtex Medical Limited: Geographical Revenue

Figure 43 Merit Medical Systems: Key Financials

Figure 44 Merit Medical Systems: Segmental Revenue

Figure 45 Merit Medical Systems: Geographical Revenue